icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Veropharm posts 1H 2009 Net Profit of $18.1 million

Veropharm posts 1H 2009 Net Profit of $18.1 million
Leading Russian pharmaceutical producer Veropharm, has posted a 1H 2009 Net Profit of $18.1 million under IFRS.

The bottom line was down 6.7% on the 1H 2008 Net Profit of $19.4 million, with EBITDA falling 19.6% year on year to $23 million, on the back of Revenues of $69.6 million, down 19.5%.

The company mostly attributed its Net result to losses from foreign currency operations. It also noted that the results in Rouble terms were more positive, with Net profit growing by 29% to 598.8 million Roubles, with EBITDA up 10.9% to 759.2 million Roubles, on an 11% year on year Revenues increase to 2.3 billion Roubles.

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.